Found 5 matching trials
Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
PHASE2This is a 12-week, multicenter, open-label extension study to evaluate the ...
Location
Tuscaloosa VA Medical Center
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
PHASE3The use of low-dose CBP dosed nightly at bedtime for FM was supported by th...
Location
Multiple Locations
Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions
PHASE2This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Location
Tuscaloosa VA Medical Center
BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)
PHASE2TNX-102 capsules \[formerly known as very low dose (VLD) cyclobenzaprine\] ...
Location
107 Scripps Drive
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
PHASE3This is an open-label, extension trial designed to evaluate safety over 12 ...